We're a Registered Charity Organization in Tanzania
Ifakara Health Institute (IHI) is officially recognized as a charitable organization under the Income Tax Act.
Certification issued on 20 March 2025 and valid until 31 December 2030.
@70MEETING: Ifakara scientist presents malaria study findings at the University of California
San Francisco, November 20, 2024 — Dr. Daniel Msellemu, a research scientist at the Ifakara Health Institute and Principal Investigator of the Outdoor Malaria Reduction by Spatial Repellent (OMRES) project, led a pivotal discussion at the University of California, San Francisco (UCSF). The event convened global health experts to share findings from the OMRES project and explore collaborative opportunities to combat outdoor malaria transmission.
Dr. Msellemu’s presentation, titled “The Use of Spatial Repellents to Reduce Malaria in Areas Where Standard Interventions Have Proven Ineffective,” showcased a groundbreaking approach to malaria control. Spatial repellents, based on volatile pyrethroids, provide hope for communities and occupations where traditional tools like insecticide-treated nets, indoor residual spraying and larviciding face environmental or behavioral challenges.
Funded by the National Institute of Health (NIH) through The Regents of the University of California, San Francisco (UCSF), the OMRES project assesses the effectiveness of a novel volatile pyrethroid spatial repellent against vector transmitted diseases in Tanzania. Launched in September 2023, the project is led by Dr. Daniel Msellemu, who serves as the Principal Investigator.
Dr. Msellemu’s presentation not only highlighted innovative research but also reinforced the importance of global collaboration in advancing malaria elimination strategies.